✨
AI Summary
- Dr. Norman Putzki discusses Novartis' Itvisma for SMA treatment.
- Details the gene replacement therapy's FDA approval for expanded age range.
- Explores the six-year development journey of STEER and STRENGTH programs.
Guests on This Episode
NP
Norman Putzki
1 podcast appearance